Stryker’s new CEO: Innovation teams now asking, “Who is going to pay for this?” (MedCityNews)
Just one month ago, Kevin Lobo took over the top spot at medical device maker Stryker Corp. On Monday, he explained the $8.5 billion corporation’s innovation strategy moving forward in his first public appearance as CEO at Cleveland Clinic’s Medical Innovation Summit.
Formerly president of J&J company Ethicon Endo-Surgery and then head of Stryker’s orthopedics unit, Lobo replaced chief financial officer Curt Hartman, who served as interim CEO following the resignation of Stephen MacMillen in Febr...